Immune Markers May Predict ITI Response in Hemophilia A: Study
2 Articles
2 Articles
The “Ilfov for Hemophilia – Uniting for Health and Hope” project was presented as an example of good practice at the prestigious European Haemophilia Consortium (EHC) Leadership Conference, held in Brussels the other day. The conference brought together leaders and experts from 27 European countries and was dedicated to promoting effective solutions to improve the lives of patients […] The post “Ilfov for Hemophilia – Uniting for Health and Hope…
Immune markers may predict ITI response in hemophilia A: Study
In people with hemophilia A, certain immune markers in the blood may help predict patient responses to immune tolerance induction (ITI) — a treatment regimen used for individuals who develop inhibitors after factor replacement therapy — according to a new study by researchers in Brazil. Inhibitors, neutralizing antibodies that develop in some patients, are a major challenge in hemophilia care because they can make replacement therapies less effe…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium